title: [A plan for risk management in the treatment of multiple sclerosis with natalizumab].
authors.forename: M V
authors.initials: MV
authors.lastname: Davydovskaia
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000187:drug effects; D061067:Antibodies, Monoclonal, Humanized; D000075202:Contraindications; D016903:Drug Monitoring / Q000592:standards; D005260:Female; D006801:Humans; D008297:Male; D009103:Multiple Sclerosis / Q000188:drug therapy*; D000069442:Natalizumab; D012308:Risk Management / Q000592:standards*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab